| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Epidemiology [S. K., C. I. A., M. L. F], Pathology [R. L.], and Gastrointestinal Medical Oncology and Digestive Diseases [P. M. L., B. L.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
A common polymorphism in the cyclin D1 gene enhances the gene’s alternate splicing. The alternatively spliced product encodes an altered protein that does not contain sequences involved in the turnover of the protein. We found that hereditary nonpolyposis colorectal carcinoma patients who were homozygous or heterozygous for the mutant allele developed colorectal cancer an average of 11 years earlier than patients who were homozygous for the normal alleles. This is the first report indicating that the cyclin D1 polymorphism influences age of onset of cancer. Because cyclin D1 plays an important role in the G1 to S phase transition of the cell cycle, our findings suggest that cells with the mutant allele accumulate mutations as a result of defective mismatch repair and may also bypass the G1-S checkpoint of the cell cycle more easily than in cells not carrying the polymorphism. The polymorphism has a dominant phenotype.
This article has been cited by other articles:
|
|
 |
|
  Z. Li, C. Wang, X. Jiao, S. Katiyar, M. C. Casimiro, G. C. Prendergast, M. J. Powell, and R. G. Pestell Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration J. Biol. Chem., March 14, 2008; 283(11): 7007 - 7015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S. Han, J.H. No, Y.T. Jeon, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2 Hum. Reprod., March 1, 2008; 23(3): 525 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Campbell, L. Edwards, J. R. McLaughlin, J. Green, H. B. Younghusband, and M. O. Woods Cytochrome P450 17A1 and Catechol O-Methyltransferase Polymorphisms and Age at Lynch Syndrome Colon Cancer Onset in Newfoundland Clin. Cancer Res., July 1, 2007; 13(13): 3783 - 3788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Izzo, T.-T. Wu, X. Wu, J. Ensor, R. Luthra, J. Pan, A. Correa, S. G. Swisher, C. K.S. Chao, W. N. Hittelman, et al. Cyclin D1 Guanine/Adenine 870 Polymorphism With Altered Protein Expression Is Associated With Genomic Instability and Aggressive Clinical Biology of Esophageal Adenocarcinoma J. Clin. Oncol., February 20, 2007; 25(6): 698 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Probst-Hensch, C.-L. Sun, D. V. D. Berg, M. Ceschi, W.-P. Koh, and M. C. Yu The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study Carcinogenesis, December 1, 2006; 27(12): 2475 - 2482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Huang, M. R. Spitz, J. Gu, J.J. Lee, J. Lin, S. M.Lippman, and X. Wu Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions Carcinogenesis, October 1, 2006; 27(10): 2034 - 2037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Hung, P. Boffetta, F. Canzian, N. Moullan, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, et al. Sequence Variants in Cell Cycle Control Pathway, X-ray Exposure, and Lung Cancer Risk: A Multicenter Case-Control Study in Central Europe Cancer Res., August 15, 2006; 66(16): 8280 - 8286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Jones, C. I. Amos, M. Pande, X. Gu, J. Chen, I. M. Campos, Q. Wei, M. Rodriguez-Bigas, P. M. Lynch, and M. L. Frazier DNMT3b Polymorphism and Hereditary Nonpolyposis Colorectal Cancer Age of Onset. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zecevic, C. I. Amos, X. Gu, I. M. Campos, J. S. Jones, P. M. Lynch, M. A. Rodriguez-Bigas, and M. L. Frazier IGF1 Gene Polymorphism and Risk for Hereditary Nonpolyposis Colorectal Cancer J Natl Cancer Inst, January 18, 2006; 98(2): 139 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yi, T.-H. Lee, J. D. Tompkins, F. Zhu, X. Wu, and C. Her Physical and Functional Interaction between hMSH5 and c-Abl Cancer Res., January 1, 2006; 66(1): 151 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Kruger, A Bier, C Engel, E Mangold, C Pagenstecher, M von Knebel Doeberitz, E Holinski-Feder, G Moeslein, K Schulmann, J Plaschke, et al. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC) J. Med. Genet., October 1, 2005; 42(10): 769 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sotamaa, S. Liyanarachchi, J.-P. Mecklin, H. Jarvinen, L. A. Aaltonen, P. Peltomaki, and A. de la Chapelle p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome Clin. Cancer Res., October 1, 2005; 11(19): 6840 - 6844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ceschi, C.-L. Sun, D. Van Den Berg, W.-P. Koh, M. C. Yu, and N. Probst-Hensch The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore Carcinogenesis, August 1, 2005; 26(8): 1457 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Spitz, X. Wu, and G. Mills Integrative Epidemiology: From Risk Assessment to Outcome Prediction J. Clin. Oncol., January 10, 2005; 23(2): 267 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. O. Shu, D. B. Moore, Q. Cai, J. Cheng, W. Wen, L. Pierce, H. Cai, Y.-T. Gao, and W. Zheng Association of Cyclin D1 Genotype with Breast Cancer Risk and Survival Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 91 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fu, C. Wang, Z. Li, T. Sakamaki, and R. G. Pestell Minireview: Cyclin D1: Normal and Abnormal Functions Endocrinology, December 1, 2004; 145(12): 5439 - 5447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shawn Jones, X. Gu, I. M. Campos, P. M. Lynch, C. I. Amos, and M. L. Frazier GSTM1 Polymorphism Does Not Affect Hereditary Nonpolyposis Colorectal Cancer Age of Onset Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 676 - 678. [Full Text] [PDF]
|
|
|
|
 |
|
 M D Crabtree, C Fletcher, M Churchman, S V Hodgson, K Neale, R K S Phillips, and I P M Tomlinson Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases Gut, February 1, 2004; 53(2): 271 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Le Marchand, A. Seifried, A. Lum-Jones, T. Donlon, and L. R. Wilkens Association of the Cyclin D1 A870G Polymorphism With Advanced Colorectal Cancer JAMA, December 3, 2003; 290(21): 2843 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Lewis, R. M. Bostick, D. Xie, Z. Deng, M. J. Wargovich, M. F. Fina, W. M. Roufail, and K. R. Geisinger Polymorphism of the Cyclin D1 Gene, CCND1, and Risk for Incident Sporadic Colorectal Adenomas Cancer Res., December 1, 2003; 63(23): 8549 - 8553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Akagi, K. Sasai, and H. Hanafusa Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation PNAS, November 11, 2003; 100(23): 13567 - 13572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lu, A. B. Gladden, and J. A. Diehl An Alternatively Spliced Cyclin D1 Isoform, Cyclin D1b, Is a Nuclear Oncogene Cancer Res., November 1, 2003; 63(21): 7056 - 7061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Solomon, Y. Wang, S. R. Fox, T. C. Lambeck, S. Giesting, Z. Lan, A. M. Senderowicz, and E. S. Knudsen Cyclin D1 Splice Variants: DIFFERENTIAL EFFECTS ON LOCALIZATION, RB PHOSPHORYLATION, AND CELLULAR TRANSFORMATION J. Biol. Chem., August 8, 2003; 278(32): 30339 - 30347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Izzo, V. A. Papadimitrakopoulou, D. D. Liu, P. L. C. den Hollander, I. M. Babenko, J. Keck, A. K. El-Naggar, D. M. Shin, J. J. Lee, W. K. Hong, et al. Cyclin D1 Genotype, Response to Biochemoprevention, and Progression Rate to Upper Aerodigestive Tract Cancer J Natl Cancer Inst, February 5, 2003; 95(3): 198 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Mitchell, S. M. Farrington, M. G. Dunlop, and H. Campbell Mismatch Repair Genes hMLH1 and hMSH2 and Colorectal Cancer: A HuGE Review Am. J. Epidemiol., November 15, 2002; 156(10): 885 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wilding, J. Straub, J. Bee, M. Churchman, W. Bodmer, C. Dickson, I. Tomlinson, and M. Ilyas Cyclin D1 Is Not an Essential Target of {beta}-Catenin Signaling During Intestinal Tumorigenesis, but It May Act as a Modifier of Disease Severity in Multiple Intestinal Neoplasia (Min) Mice Cancer Res., August 15, 2002; 62(16): 4562 - 4565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zatyka, N. F. da Silva, S. C. Clifford, M. R. Morris, M. S. Wiesener, K.-U. Eckardt, R. S. Houlston, F. M. Richards, F. Latif, and E. R. Maher Identification of Cyclin D1 and Other Novel Targets for the von Hippel-Lindau Tumor Suppressor Gene by Expression Array Analysis and Investigation of Cyclin D1 Genotype as a Modifier in von Hippel-Lindau Disease Cancer Res., July 1, 2002; 62(13): 3803 - 3811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, T. Habuchi, T. Takahashi, K. Mitsumori, T. Kamoto, Y. Kakehi, H. Kakinuma, K. Sato, A. Nakamura, O. Ogawa, et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer Carcinogenesis, February 1, 2002; 23(2): 257 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zheng, H. Shen, E. M. Sturgis, L.-E Wang, S. A. Eicher, S. S. Strom, M. L. Frazier, M. R. Spitz, and Q. Wei Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study Carcinogenesis, August 1, 2001; 22(8): 1195 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bala and P. Peltomaki CYCLIN D1 as a Genetic Modifier in Hereditary Nonpolyposis Colorectal Cancer Cancer Res., August 1, 2001; 61(16): 6042 - 6045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kong, Q. Wei, C. I. Amos, P. M. Lynch, B. Levin, J. Zong, and M. L. Frazier Cyclin D1 Polymorphism and Increased Risk of Colorectal Cancer at Young Age J Natl Cancer Inst, July 18, 2001; 93(14): 1106 - 1108. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Peltomaki Deficient DNA mismatch repair: a common etiologic factor for colon cancer Hum. Mol. Genet., April 1, 2001; 10(7): 735 - 740. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
